StockWire X
Get Free Alerts
StockWire X

Immuron Hires LifeSci Capital to Explore Mergers and Other Deals [VIDEO]

Video thumbnail
Immuron Ltd
Company Hub
Market Impact
5/10

Immuron has named LifeSci Capital as its exclusive financial advisor for a strategic review that could lead to mergers, acquisitions or licensing deals.

By Josua Ferreira -

Key Takeaways

  • Immuron has appointed LifeSci Capital as its exclusive financial advisor to look at ways to maximise shareholder value, announced on 10 November 2026.
  • The options under review include mergers, acquisitions, licensing and other deals, with no limit on what else could be considered.
  • The company warns there is no assurance the process will lead to any deal or other outcome.
  • The move follows an earlier effort, led by Pullan Consulting, to find a licensing partner for the IMM-529 C. diff program, which is ready for a mid-stage human trial.
  • Immuron will not update investors on the process until its Board of Directors approves a specific deal or disclosure is required.
This is a special feature video produced for our partner.
Topic Hubs
Biotech & Health Biotechnology Capital Markets Life Sciences Pharmaceutical Research
Most Popular
Categories

You May Also Like

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

  • Breaking ASX announcements delivered within minutes
  • Alerts delivered with expert analysis
  • Optional text alert for subscribers
  • No spam policy, unsubscribe any time
News
ASX Stock News
ASX Videos
Trending Topics▾
Capital MarketsRenewable EnergyMedical ImagingPortfolio ManagementASX 200ForexInflationInterest RatesAll OrdinariesAll Hub Pages
Analysis
Education
Free Alerts

About the Publisher

StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.

Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.

Use of Technology

We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.

While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.

Feedback and Accuracy

We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.

Editorial Standards

Disclaimer

StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).

StockWire X Pty Ltd (CAR No. 001 322 642) is a Corporate Authorised Representative of ShareX Pty Ltd (AFSL No. 519872), regulated by the Australian Securities and Investments Commission (ASIC). StockWire X is authorised to provide general financial product advice in relation to basic deposit products, securities, and managed investment schemes.

Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.

StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.

Disclosure

StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.

If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.

Disclaimer